International Clinical Trial: Intelligent Early Risk Prediction and Personalized Health Management for Gestational Metabolic Syndrome Based on Multimodal Data: Model Development and Application Validation

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115143) titled 'Intelligent Early Risk Prediction and Personalized Health Management for Gestational Metabolic Syndrome Based on Multimodal Data: Model Development and Application Validation' on Dec. 23, 2025.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Peking University Third Hospital

Condition: Gestational Metabolic Syndrome (GMS)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Observation group:2000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=301038

Published by HT Digita...